Official Title
Quality of Life and Long-term Outcomes in Patients With Pneumonia Associated With SARS-Cov2 Infection, Survivors of Intensive Care Units: a Prospective Multicenter Cohort Study
Brief Summary

Patients suffering from pneumonia due to SARS-CoV-2 infection, after admission to the Intensive Care Unit (ICU), are susceptible to development of various functional sequelae, increased risk of chronic diseases, increased mortality rates and existence of relevant impacts on their quality of life in the months and years that follow the ICU admission. The present study aims to assess the determinants of health-related quality of life and patient-centered long-term outcomes among patients recovered from SARS-COV-2 pneumonia, after discharge from the ICU, its determinants and predictors, in Portugal. It is a multicenter prospective cohort study of adult patients admitted at the ICU due to proven or suspected SARS-CoV-2 infection, included 90 days after discharge from the ICU. The primary outcome is one-year health-related quality of life assessed by the EQ-5D-3L. The secondary outcomes are all-cause mortality, rehospitalizations, return to work or study, the degree of dependence and functional capacity, symptoms of anxiety, depression and post-traumatic stress, level of physical activity and cognitive, renal and respiratory functions after ICU discharge. Investigators will collect data by means of structured telephone interviews, at a 12 months follow up period.

Unknown status
Quality of Life
Long-term Outcomes
Coronavirus Infection
Morality
Rehospitalization

Other: COVID-19 Pneumonia

Pneumonia due to proven or suspected SARS-Cov-2 infection

Eligibility Criteria

Inclusion Criteria:

- Men and women aged 18 years and older

- Admission to the intensive care unit (ICU)

- Pneumonia due to proven or suspected SARS-CoV-2 infection

Exclusion Criteria:

- Refusal to provide consent for the study by the patient or legal guardian

- ICU length of stay less than 24 hours

- Absence of telephone contact

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Portugal
Locations

Centro Hospitalar de Vila Nova de Gaia / Espinho - Unidade I
Vila Nova De Gaia, Porto, Portugal

Centro Hospitalar Universitário de São João
Porto, Portugal

Centro Hospitalar Universitário do Porto - Hospital de Santo António
Porto, Portugal

Luís Filipe Azevedo, Prof., Principal Investigator
Universidade do Porto

Universidade do Porto
NCT Number
MeSH Terms
Infections
Coronavirus Infections